Medy-Tox Inc. (KOSDAQ:086900)
 121,100
 -500 (-0.41%)
  Oct 31, 2025, 1:40 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 853.56 billion as of October 30, 2025. Its market cap has decreased by -34.09% in one year.
Market Cap 
 853.56B
Enterprise Value 
 887.48B
Revenue 
 234.63B
Ranking 
 n/a
PE Ratio 
 42.92
Stock Price 
121,100.00
Market Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 853.56B, an increase of 1,090.04%. That is a compound annual growth rate of 15.89%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 853.56B | 2.70% | 
| Dec 30, 2024 | 831.10B | -48.75% | 
| Dec 28, 2023 | 1.62T | 101.16% | 
| Dec 29, 2022 | 806.18B | -7.99% | 
| Dec 30, 2021 | 876.20B | -13.91% | 
| Dec 30, 2020 | 1.02T | -39.32% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 87.69T | 
| Celltrion | 39.50T | 
| ALTEOGEN | 25.46T | 
| SK Biopharmaceuticals | 9.08T | 
| Yuhan | 8.94T | 
| Peptron | 6.37T | 
| HLB Co., Ltd. | 6.25T | 
| PharmaResearch | 5.57T |